An 8-week diet high in cereal fiber and coffee but free of red meat does not improve beta-cell function in patients with type 2 diabetes mellitus: a randomized controlled trial by Karusheva, Yanislava et al.
RESEARCH Open Access
An 8-week diet high in cereal fiber and
coffee but free of red meat does not
improve beta-cell function in patients with
type 2 diabetes mellitus: a randomized
controlled trial
Yanislava Karusheva1,2, Lejla Kunstein1,2,3, Alessandra Bierwagen1,2, Bettina Nowotny1,2, Stefan Kabisch2,4,5,
Jan B. Groener6, Ann Kristin Fleitmann1, Christian Herder1,2, Giovanni Pacini7, Klaus Strassburger2,8,
Hans-Ulrich Häring2,9, Peter P. Nawroth6, Andreas F. H. Pfeiffer2,4,5, Volker Burkart1,2, Karsten Müssig1,2,3,
Michael Roden1,2,3 and Julia Szendroedi1,2,3*
Abstract
Background: Higher dietary intake of fibers and coffee, but lower red meat intake is associated with reduced risk
for type 2 diabetes in epidemiological studies. We hypothesized that a calorie-restricted diet, which is high in fiber
and coffee, but free of red meat, improves beta-cell function in patients with T2D.
Methods: In a randomized parallel-group pilot trial, obese type 2 diabetes patients were randomly allocated to
consume either a diet high in cereal fiber and coffee, but free of red meat (n = 17) (L-RISK) or a diet low in fiber,
free of coffee but high in red meat (n = 20) (H-RISK) for 8 weeks. Insulin secretion was assessed from glucagon
stimulation tests (GST) and mixed-meal tolerance tests (MMTT) before and after dietary intervention.
Results: Both diets resulted in comparable reduction of fasting concentrations of insulin (H-RISK -28% vs. L-RISK -32%,
both p < 0.01), C-peptide (H-RISK -26% vs. L-RISK -30%, both p < 0.01) and blood glucose (H-RISK -6.8%, p < 0.05 vs.
L-RISK -10%, p < 0.01). Gastric inhibitory peptide (GIP) secretion increased by 24% after 8 weeks in the L-RISK only
(p < 0.01). However, GST and MMTT showed no differences in insulin secretion after intervention.
Conclusions: Calorie restriction independent of the intake of fiber, coffee or meat failed to improve beta-cell function,
but improved GIP secretion in obese patients with type 2 diabetes.
Trial registration: Registration at Clinicaltrials.gov, Identifier number: NCT01409330, Registered 4 August 2011 –
Retrospectively registered.
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Background
Epidemiological studies provided evidence that high
fiber, high coffee intake or reduced red meat consump-
tion may delay the onset of type 2 diabetes (T2D) and
have beneficial effects on mechanisms underlying its
pathogenesis [1–4]. Among others, these dietary compo-
nents were used to calculate the probability of develop-
ing T2D in the European Prospective Investigation into
Cancer and Nutrition (EPIC)-Potsdam study [5].
Protein- and fiber-rich products, alongside with caffeic
acid and others were shown to enhance insulin secre-
tion, whereas restriction from red meat proved to be a
risk-reducing factor for the development of T2D [6–8].
The addition of fiber to a proinflammatory high-fat
high-calorie meal had beneficial anti-inflammatory
and metabolic effects [9]. Moreover, a high-fiber diet
for 16 weeks decreased concentrations of fasting glu-
cose [10], but also acute intake attenuated hypergly-
cemia [11].
Despite the mostly consistent epidemiological data,
intervention studies revealed more diverse results.
Indeed, acute coffee consumption shows variable
health effects from those achieved by long-term
consumption. One single cup of coffee aggravated
postprandial glucose excursion in healthy individuals
and in patients with T2D [12], whereas regular coffee
intake did not influence glucose homeostasis despite
its anti-inflammatory effects [13]. Moreover, the
EPIC-Potsdam revealed an association between higher
red meat consumption and increased risk for T2D
[5]. Habitual excess meat intake can cause inflamma-
tory responses as well as oxidative stress [14–17]. In
a randomized controlled study, patients with T2D,
who abstained from red meat consumption over 4
weeks, showed an increased proportion of serum
polyunsaturated fatty acids, which may have a favor-
able effect on endothelial function, coronary artery
disease and albuminuria [18]. Positive associations be-
tween red meat consumption and the risk of T2D
was evident for both processed and unprocessed
preparations [19]. Elevated postprandial amino acid
concentrations stimulate insulin secretion without af-
fecting glycaemia [20]. However, diets high in protein
from animal or plant sources reduced hepatic fat,
hepatic necroinflammation and insulin resistance [21].
Moderately supplementing meat protein with soy pro-
tein resulted in improvement of insulin sensitivity as
well as total and LDL cholesterol [22]. While these
studies tested the effects of single dietary modifica-
tions on metabolism, we recently reported on the
comparison of two low-energy diets differing in cof-
fee, fiber as well as red meat intake [23, 24]. Both di-
ets equally improved insulin sensitivity and cardiac
vagal function in relation to improved oxidative
glucose utilization, but failed to affect insulin secre-
tion during an intravenous glucose tolerance test in
obese patients with T2D. This test reflects only the
glucose-dependent component of insulin secretion
under intravenous rather than oral glucose loading
conditions, thereby excluding the role of glucagon,
incretins and combined effects of other nutrients on
in vivo beta-cell function [25]. We hypothesized that
a calorie-restricted diet, high in fiber and coffee, but
free of red meat, according to the German Diabetes
Risk Score (GDRS), improves beta-cell function as
assessed by insulin secretion in patients with T2D. To
investigate the hypothesis we used both glucagon
stimulation and mixed-meal tolerance tests which are
established methods for evaluating beta-cell secretory
capacity in T2D [26].
Methods
Patients and study design
This study was performed in a subgroup of participants
of a randomized controlled parallel group trial [23, 24],
who underwent two additional tests for beta-cell func-
tion on two different days spaced by 8 weeks. Type 2
diabetes patients (18–69 years of age, body mass index
(BMI) ≥30 kg/m2, known diabetes duration ≤5 years),
treated by lifestyle changes and/or with metformin and/
or acarbose were included. Exclusion criteria comprised
HbA1c > 75mmol/mol (9.0%), diabetes types other than
T2D and acute or chronic diseases including inflamma-
tory diseases or cancer. Patients taking any medication
affecting the immune system or insulin sensitivity, other
than metformin, were also excluded.
The details of the protocol have been reported else-
where [23]. A total of 37 obese patients with T2D com-
pleted this trial (Additional file 1: Figure S1). A time line
of all experiments is given in Additional file 2: Figure S2.
The primary endpoint was the M-value derived from the
hyperinsulinemic euglycemic clamp test to assess
whole-body insulin sensitivity. Based on previously re-
ported data, a mean M-value of 3.8 ± 1.7mg*kg− 1 *min− 1
was expected prior to the start of the intervention. For
every percentage increase of the M-value, the ratio be-
tween the percentage increase of the M-value in the
L-RISK group and the percentage increase in the H-RISK
group was calculated. Assuming a 20% increase in L-RISK
and 16% increase in H-RISK gives a ratio of 1.2 with a
conservative estimate of a coefficient of variation of 0.3
and an intraindividual correlation of 0.7. This calculation
yields a statistical power of 91%. In order to ensure suffi-
cient numbers of patients per group, we recruited 29/30
persons per group (Additional file 1: Figure S1). The given
number of analysed participants of n = 15–19 (H-RISK)
und n = 13–16 (L-RISK) allows detecting moderate effect
sizes (Cohen’s d = 0.8) for baseline and 8 week-follow-up
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differences of measures of beta-cell function from MMT
with a power of at least 80%. Thus, the present study was
sufficiently powered to detect changes in beta-cell
function.
The participants were either assigned to a diet low
in fiber (≤10 g/day), coffee-free and high in red meat
(≥150 g/day) (H-RISK, n = 20) or to a diet high in
cereal fiber from wheat and rye (100 g of wholegrain
crispread and 250–300 g of wheat/rye wholegrain
bread) and fresh-brewed coffee (≥5 cups/day contain-
ing 7–8 g coffee powder each, the standard size of
coffee cups is 125–150 ml in Europe [5]) and free of
red meat (L-RISK, n = 17). All participants gave written
informed consent before inclusion in the study. The study
was performed according to the Declaration of Helsinki,
approved by the ethics committee of the Medical Faculty
of Heinrich Heine University Düsseldorf and registered at
clinicaltrials.gov (Identifier number: NCT01409330).
Dietary monitoring
Before the start of the intervention, the participants doc-
umented their nutritional behavior. During the interven-
tion, all participants received individually calculated
daily nutritional protocols, which they had to follow and
were asked to document any changes. They had to re-
turn the completed sheets to monitor compliance. Dur-
ing the intervention, individually documented food
intake was used to assess the participants’ adherence to
the study protocol and to ensure consistency of food
intake.
Mixed-meal tolerance test
After overnight fasting for 12 h, participants ingested a
standardized liquid meal (237 ml Boost® High Protein,
Nestle HealthCare Nutrition, Inc., Florham Park, NJ,
USA) containing 33 g carbohydrates, 6 g fat and 15 g
protein within 5 min starting at zero time. Blood samples
were taken at min − 15, 0, + 30, + 60, + 90, + 120 and +
180 for measurements of glucose, insulin and C-peptide
levels to calculate incremental areas under the curve
(iAUC), using the trapezoidal rule after subtracting the
basal (fasting) values. Insulinogenic index (IGI) was cal-
culated for assessing beta-cell function from the ratio of
the difference between insulin levels at baseline and at
30 min to the same difference for glucose levels [27].
The mean basal values of blood glucose and insulin have
been previously reported [23].
Glucagon stimulation test
After overnight fasting for 12 h, blood samples were obtained
for measurements of fasting glucose, insulin and C-peptide
levels. At zero time, a bolus of 1mg glucagon (GlucaGen;
Novo Nordisk, Mainz, Germany) was injected intravenously
and a second blood sample was obtained at min + 6 for
measurements of insulin and C-peptide levels [26]. The dif-
ference between C-peptide and insulin concentrations be-
tween 0min and 6min was used to assess
glucagon-stimulated C-peptide and insulin secretion capaci-
ties (ΔC-peptide and Δinsulin, respectively) [28].
Laboratory analyses
Serum samples were analyzed as described [26]. Briefly,
blood glucose concentration was measured by the hexo-
kinase method (EPOS 5060 analyzer; Eppendorf, Ham-
burg, Germany). Serum C-peptide and insulin were
measured by radioimmunoassay (intra-assay coefficient
of variation (CV) for all, 1%; interassay CV, 6–7% and
5–9%, respectively; Millipore, St. Charles, MO, USA)
[29]. Glucagon-like peptide 1 (GLP-1) and gastric inhibi-
tor peptide (GIP) were measured using ELISA (GLP-1:
interassay CV, 10%; TECOmedical, Sissach, Switzerland;
GIP: interassay CV, 12%; Millipore) [29]. Other parame-
ters of clinical chemistry (total cholesterol, low-density
lipoprotein (LDL), high-density lipoprotein (HDL) and
triglycerides (TG)) as well as liver enzymes were mea-
sured on a Cobas c311 analyzer (Roche, Diagnostics,
Mannheim, Germany) [26].
Statistical analyses
The values are shown as mean ± standard error of the
mean (SEM). Assuming that the two experimental sam-
ples follow Gaussian distribution, statistical significance of
differences was assessed with the two-tailed t-test. The ef-
fects of both diets on blood glucose and incretin levels
and on parameters reflecting insulin secretion were ana-
lyzed by repeated measurement two-way ANOVA to com-
pare diet-induced changes between groups as well as
effects of time, diet and time - diet interaction. Analyses
adjusted for BMI, weight loss and medication were per-
formed to exclude these as confounding factors.
Results
Anthropometry
Patients in both H-RISK and L-RISK groups did not dif-
fer in age, body mass index, glycemic control and lipide-
mia and had comparable blood glucose-lowering
medications [23].
Dietary composition and body weight
At baseline, all participants of both groups had compar-
able calorie, macronutrient, red meat, coffee and cereal
fiber intake. All participants adhered to the nutritional
protocols as evident by a 6.9-fold higher intake of cereal
fiber in the L-RISK group (p < 0.0001), a 1.3-fold higher
intake of red meat and the absence of coffee consump-
tion in the H-RISK group compared to the L-RISK
group (both p < 0.0001). As a result of the dietary advice,
participants of both groups consumed less total energy
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and fat, but more carbohydrates and proteins during the
intervention [23].
Mixed-meal-stimulated beta-cell function
At baseline, fasting glucose, insulin and C-peptide
(Fig. 1a, c, e) as well as GLP-1 and GIP were similar
between both groups. Fasting blood glucose levels
measured on the day of the MMTT decreased by
10% (− 11.9 ± 2.8 mg/dl, p < 0.01) in the L-RISK group
and by 6.8% (− 7.9 ± 2.9 mg/dl, p < 0.05) in the
H-RISK group (Fig. 1a). Previously reported blood
glucose levels were measured on the day of the
hyperinsulinemic euglycemic clamp test (HEC), as in-
sulin sensitivity was the primary endpoint [23].
Fasting blood glucose levels assessed before MMTT
were not different compared to those measured be-
fore HEC (p > 0.05 for both groups). Fasting insulin
concentration decreased by 28% (− 5.1 ± 1.4 μU/ml,
p < 0.01) in the H-RISK group and by 32% (− 6.8 ± 1.9
μU/ml, p < 0.01) in the L-RISK group (Fig. 1c). Fast-
ing C-peptide concentration decreased by 26% (− 0.8
± 0.2 ng/ml, p < 0.01) in the H-RISK group and by
30% (− 1.0 ± 0.3 ng/ml, p < 0.01) in the L-RISK group
(Fig. 1e). There were no differences of the changes in
fasting glucose and hormone concentrations between
both groups. IGI remained unchanged in the H-RISK
group before (138.5 ± 15.0) and after (141.2 ± 24.9) as
well as in the L-RISK group before (176.0 ± 20.0) and
after (206.6 ± 43.2) dietary intervention, showing no
change in beta-cell function.
At baseline, iAUC for glucose, insulin, C-peptide, GLP-1
and GIP (Fig. 1b, d, f, g, h) were similar between both
groups. After dietary intervention, iAUC for glucose de-
creased by 20% (− 1109 ± 507mg/dl*180min, p < 0.05)
only in the H-RISK group (Fig. 1b). The iAUC for insulin
and C-peptide (Fig. 1d, f ) neither changed during L-RISK
nor during H-RISK diets. The iAUC for GIP increased
only after the L-RISK diet (+ 8152 ± 1993 pg/ml*180min,
p < 0.01) (Fig. 1h), whereas the iAUC for GLP-1 remained
unchanged after both diets. Further statistical analyses of
MMTT revealed no differences in the changes of all pa-
rameters from week 0 to week 8 between the H-RISK and
L-RISK groups. After adjustments for BMI, weight loss
and medication, the results of the analyses remained virtu-
ally unchanged.
Glucagon-stimulated beta-cell function
In the L-RISK group, compared to the H-RISK group,
Δinsulin and ΔC-peptide concentrations were higher be-
fore the intervention (both p < 0.01) (Fig. 2a, b). In the
H-RISK group, Δ C-peptide concentration increased by
27% (p < 0.01). No changes of Δ insulin were observed
in either group. After further adjustments for BMI,
weight loss and medication, the results of the analyses
remained virtually unchanged.
Discussion
Eight-week calorie restricted diets, differing in the intake
of cereal fibers, coffee and red meat, both failed to im-
prove mixed-meal- or glucagon-stimulated beta-cell
function, but decreased fasting insulinemia in obese pa-
tients with near-normoglycemic T2D. Both EPIC and
the dietary-based diabetes-risk score (DDS) [30]
weighted positively low-fat dairy, fiber and coffee and
negatively red meat. To design our dietary intervention,
we used dietary components established as individual
markers of high/low risk of T2D, but not previously
used in this very combination. We cannot exclude the
possibility of interaction between single dietary compo-
nents. This dietary multimodal intervention, however,
neither evaluated single dietary components nor focused
on effects of macronutrients’ components.
In healthy humans, high-fiber diet was found to en-
hance insulin secretion, indicating improvement of
beta-cell function [6]. It is speculated that fiber-rich
products contain specific compounds such as trace min-
erals and phenolic compounds enhancing the acute
phase of insulin secretion. In fact, previous studies
showed that high-fiber intake lowers the risk of type 2
diabetes [31] and improves glycemic control in patients
with overt type 2 diabetes [4]. However, patients of these
studies featured mostly diabetes duration of > 5 years
and markedly impaired beta-cell function. In the present
study, the absence of any effect of modulating fiber in-
take on insulin secretion may be due to the rather pre-
served beta-cell function, which probably cannot be
further improved by mild to moderate dietary interven-
tions. Nevertheless, we applied an inclusion criterion for
known diabetes duration ≤5 years to keep the study
group homogenous and the pancreatic insulin produc-
tion preserved. Previous studies revealed that patients
with T2D for up to 6 years duration are more likely to
reach a remission of the disease through a dietary or life-
style intervention [32, 33] suggesting preserved beta-cell
secretion capacity.
However, both fasting insulin and C-peptide de-
creased most likely corresponding to improved insulin
sensitivity in both groups as previously shown [23]. In
parallel, both groups showed a reduction of fasting
blood glucose levels after 8 weeks of intervention, so
both diets lead to reducing hyperglycemia. In the
H-RISK group iAUC for glucose decreased by about
20%. Furthermore, Δ C-peptide increased by about
27% in the H-RISK group only. In the absence of any
changes of Δ insulin, this finding does not indicate a
physiologically relevant change of insulin secretion.
Of note, both Δ C-peptide and Δ insulin remained
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Fig. 1 Fasting concentrations of blood glucose (a), insulin (c), C-peptide (e), as well as mixed-meal-induced beta-cell function (means±SEM) from
incremental areas under the respective concentration-time curves (iAUC; b, d, f) before and after dietary intervention in a subgroup of
participants of the H-RISK group (n = 19) and L-RISK groups (n = 16). Glucagon-like peptide (GLP-1) (g) and gastric inhibitor peptide (GIP) (h) from
incremental areas under the respective concentration-time curves
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unchanged in the L-RISK group. Results of observa-
tional studies support the protective effects of coffee
and reduced red meat consumption [3, 34, 35]. How-
ever, in the setting of our study in patients with overt
T2D, these dietary factors also reduce hyperglycemia,
but fail to affect insulin secretion.
Of note, coffee consumption of ≥5 cups/day contain-
ing 7–8 g coffee powder each, also failed to affect insulin
secretion. This is in line with cross-sectional analyses of
1440 Japanese adults using the homeostatic model assess-
ment as a surrogate of insulin secretion [36] and of 1088
elderly Swedish men, assessing the early insulin response
during an oral glucose tolerance test (OGTT) [37].
The absence of any effect of dietary modulation of fi-
bers, coffee and meat on insulin secretion in the present
study could be due to the short intervention period. In
our study, 8 weeks of dietary intervention did not affect
insulin and C-peptide secretion in any of the groups as
assessed by MMTT. However, in the L-RISK group there
was an increase of GIP concentration during MMTT
after dietary intervention. This observation corresponds
with the results of a previous study showing a decrease
of GIP secretion after a high-fat meal, but a preservation
of GIP secretion after a high-fiber meal [38].
The similar decrease in fasting insulin and C-peptide
levels suggests a comparable improvement in - particu-
larly hepatic - insulin sensitivity by both H-RISK and
L-RISK diets. Our initial study preceding this subgroup
analysis found that both diets increase whole body insu-
lin sensitivity, without changes in insulin-mediated sup-
pression of endogenous glucose production as assessed
from the hyperinsulinemic euglycemic clamp test, which
however was not designed to specifically test hepatic in-
sulin sensitivity [23, 24]. Of note, both diets also lowered
the increased hepatic fat content, which is generally
linked to hepatic insulin resistance [39]. With regard to
higher coffee consumption, the observed improvements
in insulin sensitivity, but not insulin secretion are in line
with some cross-sectional analyses [36, 37], but not with
a randomized crossover-study in 26 healthy humans,
who drank one liter coffee every day for 4 weeks [40].
The present study benefits from examining beta-cell
function with two independent methods and careful
dietary monitoring, but suffers from the limited inter-
vention period of 8 weeks and the small sample sizes. In
addition, this study cannot account for potential effects
of different preparation and processing of macronutri-
ents. Moreover, a disadvantage of the study was that the
baseline insulin and C-peptide secretory capacity was
different between the two intervention groups despite
randomization. To detect further possible effects
particularly on insulin secretion, the comprehensive
metabolic phenotyping of a several fold higher number
of participants would have been required. In addition,
both dietary interventions led to a minor (< 5%) weight
loss, which could have nevertheless masked certain
diet-specific effects.
Conclusion
In conclusion, a short-term dietary modification with
high cereal fibers and coffee, but free of red meat does
not improve beta-cell function compared to a diet low in
fibers, lacking coffee and high in red meat. Any reduc-
tion of hyperglycemia by both diets is not due to
changes in insulin secretion.
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